Immunology-Based Platforms Launch Novel Treatments in Ovarian Cancer

May 24, 2013

In continuing coverage, Oncology Times covered research presented byLana Kandalaft, PharmD, PhD, MTR, a research assistant professor of Obstetrics and Gynecology and director of clinical development and operations in Penn Medicine’s Ovarian Cancer Research Center during the annual meeting of the American Association for Cancer Research on a personalized immunotherapy for ovarian cancer.

Oncology Times article